{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:32:10Z","timestamp":1791189130456,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T00:00:00Z","timestamp":1236038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Topical steroids are first\u2010line medication to control nasal polyposis (NP), a disease with long\u2010term clinical course.<\/jats:p><jats:p><jats:bold>Objective:\u2002<\/jats:bold> The aim of this study was to evaluate the efficacy and safety of fluticasone propionate aqueous nasal spray (FPANS) 200\u2003\u03bcg twice a day (bd) after 1\u2003month of treatment, and to compare FPANS 200\u2003\u03bcg bd and FPANS 200\u2003\u03bcg once a day (od) in maintenance and long\u2010term treatment.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Double\u2010blind, placebo\u2010controlled, 8\u2010month study with three treatment periods (1\u2010month acute period followed with 1\u2010month maintenance period and 6\u2010month follow\u2010up period) was carried out. Group 1 received FPANS 200\u2003\u03bcg bd, during acute, maintenance and follow\u2010up periods, Group 2 received FPANS 200\u2003\u03bcg bd during acute period and FPANS 200\u2003\u03bcg od during maintenance and follow\u2010up periods, and Group 3 received placebo during acute and maintenance periods and FPANS 200\u2003\u03bcg bd during follow\u2010up period. Endpoints were change from baseline in clinic peak nasal inspiratory flow (PNIF), domiciliary evening PNIF, intensity of symptoms and polyposis grade.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> After acute period and maintenance periods, FPANS 200\u2003\u03bcg bd was significantly more effective than placebo on all endpoints and more effective than FPANS 200\u2003\u03bcg od after 1\u2010month maintenance period on clinic PNIF, evening PNIF, obstruction, percentage of days with no sense of smell and percentage of nights with no disturbances. The two doses were similar on other endpoints. After the 6\u2010month follow\u2010up period, there was no difference between the two doses of FPANS at all efficacy endpoints. The safety profile of FPANS did not highlight any new or unanticipated adverse events.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> The study demonstrated the efficacy of FPANS 200\u2003\u03bcg bd in acute treatment and FPANS 200\u2003\u03bcg od as a sufficient dose to maintain a long\u2010term efficacy in the treatment for NP.<\/jats:p>","DOI":"10.1111\/j.1398-9995.2009.01938.x","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T09:35:27Z","timestamp":1236072927000},"page":"944-950","source":"Crossref","is-referenced-by-count":40,"title":["Long\u2010term study of fluticasone propionate aqueous nasal spray in acute and maintenance therapy of nasal polyposis"],"prefix":"10.1111","volume":"64","author":[{"given":"R.","family":"Jankowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2010M.","family":"Klossek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Attali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,5,11]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps","volume":"18","author":"Fokkens WJ","year":"2005","journal-title":"Rhinol Suppl"},{"key":"e_1_2_6_3_2","first-page":"1","article-title":"On behalf of the European position paper on rhinosinusitis and nasal polyps group","volume":"20","author":"Fokkens W","year":"2007","journal-title":"Rhinology"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565110-00006"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-198912000-00012"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1984.tb02203.x"},{"key":"e_1_2_6_7_2","first-page":"173","article-title":"Clinical factors influencing the eosinophil infiltration of nasal polyps","volume":"40","author":"Jankowski R","year":"2002","journal-title":"Rhinology"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00151829-200605020-00003"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1472-9725.2003.00061.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01225.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/28.4.717"},{"key":"e_1_2_6_12_2","first-page":"21","article-title":"Aspirin\u2010induced asthma and nasal polyps","volume":"430","author":"Ogino S","year":"1986","journal-title":"Acta Otolaryngol Suppl"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00688.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(05)80142-3"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.2500\/108854196778662246"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.1487"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00725.x"},{"key":"e_1_2_6_18_2","first-page":"8","article-title":"Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long\u2010term intranasal steroid treatment","volume":"44","author":"Alobid I","year":"2006","journal-title":"Rhinology"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2006.08.010"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62468-4"},{"key":"e_1_2_6_21_2","first-page":"298","article-title":"Insufficiency of ethmoidectomy in the treatment of nasal polyposis","volume":"108","author":"Jankowski R","year":"1991","journal-title":"Ann Otolaryngol Chir Cervicofac"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.1986.tb02000.x"},{"key":"e_1_2_6_23_2","first-page":"211","article-title":"Assessing the reproducibility of nasal spirometry parameters in the measurement of nasal patency","volume":"39","author":"Harar RP","year":"2001","journal-title":"Rhinology"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00779.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.112.6.1547"},{"key":"e_1_2_6_26_2","first-page":"32","article-title":"Peak nasal inspiratory flow; normal range in adult population","volume":"44","author":"Ottaviano G","year":"2006","journal-title":"Rhinology"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2000.00695.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)63180-8"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.127.4.447"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730040-00004"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.2009.01938.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.2009.01938.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:14:26Z","timestamp":1697429666000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.2009.01938.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1398-9995.2009.01938.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.2009.01938.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,11]]}}}